Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
VERU
VERU INC.
NASDAQ
$2.34
▼ DOWN 4.10% (-0.10)

KEY STATISTICS

Market Cap$39.16 M
52w High$7.33
52w Low$2.05
Dividend Yield0.37%
FrequencyQuarterly
P/E-3.66
Volume207.49K
Shares Out.16.05M

COMPANY

LEADERSHIP

Mitchell S. Steiner
CHIEF EXECUTIVE
Mitchell S. Steiner

COMPENSATION 2026

Salary$836,211
Stock Awards$0
Incentive Plan Pay$636,156
All Other Comp.$14,000
Total$1,649,663

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 11, 1999
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
20

PRICE TARGET

Target High$5.00
Target Low$3.00
Target Median$4.00
Target Consensus$4.00

UPCOMING EARNINGS

DateNov 26, 2026
DayThursday
Rev. Est.—
NOV
26
THU

SPLIT RECORD

DATETYPERATIO
2025-08-11Reverse1:10

PRICE

$2.34 ▼ DOWN 4.10% (−$0.10)
OVERLAYS
$2.37$2.40$2.439:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.34

About Veru Inc.

https://www.verupharma.com ↗

Veru Inc. is a Miami-based biopharma company developing cancer treatments and commercial products like FC2 female condoms, with drug candidates in various clinical trial phases for cancers, COVID-19, and other conditions.

INDUSTRY

Biotechnology

A PRODUCT VERU INC. IS KNOWN FOR

Enobosarm
Enobosarm

Enobosarm is a late-stage oral SARM developed to be combined with GLP-1 drugs to improve weight loss by preserving muscle mass and physical function while promoting fat reduction.

COMPETITORS

COMPETITOR
ARVN COMPARE
LLY COMPARE
REGN COMPARE
RLAY COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
13
LISTED HERE
2
RANKED BY POSITION SIZE
VTI
0.00% · 531.9K
IWC
0.01% · 49.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
80.98%
HOLDERS
113
TOP 12 OF 113 · RANKED BY POSITION SIZE
Blackrock Inc.
7.7M sh · $6.44M
Pvg Asset Management Corp
1.6M sh · $958.44K
Alyeska Investment Group, L.P.
1.0M sh · $2.21M
Potomac Capital Management, Inc.
654.0K sh · $470.88K
Vanguard Group Inc
640.7K sh · $2.43M
Advisor Group Holdings, Inc.
235.8K sh · $113.17K
Millennium Management LLC
231.6K sh · $880.09K
Oppenheimer & Co Inc
210.8K sh · $659.94K
Gsa Capital Partners Llp
195.7K sh · $419K
Geode Capital Management, LLC
184.6K sh · $408.12K
Nuveen Asset Management, LLC
178.6K sh · $116.15K
Blackrock, Inc.
167.1K sh · $522.97K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF SCIENTIFIC OFFICER
BARNETTE K GARY
Purchase · 1.8K shares
2026-08-13
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
STEINER MITCHELL SHUSTER
Purchase · 604.0K shares
2026-05-04
★
OFFICER: CHIEF ADMIN OFFICER AND CFO
Greco Michele
Purchase · 164.0K shares
2026-05-04
★
DIRECTOR
Katzovitz Loren Mark
Purchase · 102.0K shares
2026-05-04

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
OUTPERFORM 1
2 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY Oppenheimer OUTPERFORM

SECTORS PEERS

PEERPRICE
PYPD$5.30COMPARE
RNXT$1.69COMPARE
ANVS$1.15COMPARE
CELU$1.39COMPARE
DYAI$0.44COMPARE
RVPH$0.48COMPARE
BTAI$0.07COMPARE